Critical Care Building Will Serve Most Fragile Patients
Cincinnati Children’s is launching the largest expansion project in our history: a new eight-story patient care building located on our Burnet campus that will add more beds for kids needing the most critical care.
By providing improved spaces for newborn care, pediatric intensive care, cardiac intensive care, bone marrow transplants and advanced cancer therapies, the new building will transform services for our sickest, most medically complex patients. It will also accommodate a new emergency department, an expanded pharmacy, kitchen space and respite spaces for families and staff.
Our current main campus was initially built to accommodate 350 inpatients, yet on many days we are now seeing more than 500 inpatients. Although we’ve added around 100 beds in the last decade, it hasn’t been enough to keep up with growing demand.
Our vision is to be the leader in improving child health. That includes the health of every child — from those with routine colds to those facing the most challenging and life-threatening illnesses. The Critical Care Building will provide new and exciting opportunities for us to draw closer to that vision, and to make sure that each child who comes through our doors will receive the very best care possible.
Cincinnati Children’s Ranks No. 3 in Nation
Thanks to you, we did it again! For the seventh consecutive year, U.S. News & World Report recognized Cincinnati Children’s as one of the top three pediatric hospitals in the nation. We also placed among the top five in seven specialties. We are overwhelmed with gratitude and humbled by the honor.
But we couldn’t do it without you. Your partnership empowers us to create more vibrant, healthy futures for children everywhere. Families travel from across the country and around the globe to have access to the world-renowned specialists and innovative care found right here in Cincinnati.
Thank you. See a full list of our rankings.
Promising Research Could Provide Alternative to Organ Transplants
For a patient with end-stage liver disease, the only current treatment is a liver transplant—but that could soon change.
A team of international researchers at Cincinnati Children’s, led by Takanori Takebe, MD, are bio-engineering human mini organs—called organoids—that mimic the structure and function of a real liver. This innovation has the potential to revolutionize care for kids awaiting organ transplants.
The researchers in Dr. Takebe’s lab are currently studying babies born with metabolic liver disease. Unable to receive a liver transplant until at least 6 months of age, the use of organoids could provide interim treatment for these fragile newborns, saving precious lives. The team is hopeful that the proven benefits in congenital patients will allow this work to expand and provide treatment for an array of liver diseases.
While this research presents incredible hope, advancing early findings will require the support of many. “When we achieve an alternative approach to liver transplantation, it will be not only because of our dedicated research team,” Dr. Takebe says, “but because of the commitment of donors to a future where all kids have the potential to be healthy and vibrant.”